Vladimir Semiglazov Selected Research

Vladimir Semiglazov Research Topics

Disease

40	Breast Neoplasms (Breast Cancer) 01/2023 - 08/2005
12	Neoplasms (Cancer) 09/2023 - 08/2005
6	Inflammatory Breast Neoplasms 06/2016 - 01/2010
4	Febrile Neutropenia 06/2016 - 05/2013
3	Neutropenia 01/2020 - 05/2013
3	Disease Progression 01/2020 - 11/2011
3	Pathologic Complete Response 05/2015 - 12/2005
2	Triple Negative Breast Neoplasms 09/2023 - 07/2014
2	Heart Failure 01/2020 - 01/2010
2	Neoplasm Metastasis (Metastasis) 05/2015 - 01/2015
2	Hypertension (High Blood Pressure) 01/2015 - 05/2013
2	Nausea 02/2014 - 08/2005
1	Noninfiltrating Intraductal Carcinoma (DCIS) 07/2022
1	Left Ventricular Dysfunction 01/2020
1	Stomatitis 01/2015
1	Fatigue 01/2015
1	Thrombosis (Thrombus) 05/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2014
1	Diarrhea 02/2014
1	Adenocarcinoma 09/2013
1	Pneumonia (Pneumonitis) 05/2013
1	Cellulitis 05/2013
1	Breast Cancer 3 01/2010
1	Anemia 09/2005
1	Exanthema (Rash) 08/2005
1	Mucositis 08/2005

Drug/Important Bio-Agent (IBA)

18	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2010
10	Docetaxel (Taxotere)FDA Link 01/2020 - 11/2006
6	Hormones (Hormone)IBA 07/2022 - 02/2009
6	pertuzumabIBA 01/2020 - 01/2012
6	Paclitaxel (Taxol)FDA LinkGeneric 03/2018 - 12/2005
6	Fluorouracil (Carac)FDA LinkGeneric 02/2014 - 12/2005
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2014 - 12/2005
5	Capecitabine (Xeloda)FDA Link 01/2019 - 01/2012
5	human ERBB2 proteinIBA 03/2018 - 03/2011
5	Methotrexate (Mexate)FDA LinkGeneric 01/2014 - 12/2005
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014 - 12/2005
5	Estrogen ReceptorsIBA 04/2012 - 12/2005
4	ErbB Receptors (EGF Receptor)IBA 01/2018 - 10/2011
3	AnthracyclinesIBA 03/2018 - 10/2011
2	Immune Checkpoint InhibitorsIBA 09/2023 - 06/2022
2	Drug CombinationsIBA 06/2022 - 02/2015
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
2	Lapatinib (GW572016)FDA Link 05/2015 - 02/2012
2	taxaneIBA 01/2015 - 04/2012
2	Bevacizumab (Avastin)FDA Link 05/2013 - 01/2012
2	Monoclonal AntibodiesIBA 02/2012 - 01/2010
2	Letrozole (Femara)FDA LinkGeneric 11/2011 - 06/2009
2	Estrogens (Estrogen)FDA Link 11/2011 - 02/2009
1	Granzymes (Granzyme)IBA 09/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	eribulin FDA Link 01/2019
1	130-nm albumin-bound paclitaxelIBA 03/2018
1	Phenobarbital (Luminal)FDA Link 03/2018
1	Albumin-Bound Paclitaxel FDA Link 03/2018
1	Biosimilar PharmaceuticalsIBA 01/2018
1	antineoplaston A10 (A 10)IBA 06/2016
1	Indicators and Reagents (Reagents)IBA 06/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 06/2016
1	RamucirumabIBA 01/2015
1	Leucovorin (Folinic Acid)FDA Link 02/2014
1	eniluracilIBA 02/2014
1	ParaffinIBA 01/2014
1	Formaldehyde (Formol)FDA Link 01/2014
1	exemestane (Aromasin)FDA Link 04/2012
1	Tyrosine Kinase InhibitorsIBA 02/2012
1	AntigensIBA 11/2011
1	Immunoglobulins (Immunoglobulin)IBA 11/2011
1	epitumomabIBA 11/2011
1	Taxoids (Taxanes)IBA 10/2011
1	Alkylating AgentsIBA 10/2011
1	Everolimus FDA Link 06/2009
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2009
1	Aromatase InhibitorsIBA 02/2009
1	Tamoxifen FDA LinkGeneric 02/2009
1	thiamine triphosphorate (TTP)IBA 11/2006
1	Epoetin Alfa (Epogen)FDA Link 09/2005
1	Hemoglobins (Hemoglobin)IBA 09/2005
1	TOR Serine-Threonine KinasesIBA 08/2005
1	temsirolimus FDA Link 08/2005

Therapy/Procedure

15	Therapeutics 01/2023 - 12/2005
14	Neoadjuvant Therapy 01/2022 - 04/2006
12	Drug Therapy (Chemotherapy) 01/2023 - 09/2005
3	Adjuvant Chemotherapy 03/2011 - 11/2006
2	Immunotherapy 09/2023 - 06/2022
2	Intravenous Administration 09/2013 - 09/2012
1	Radiotherapy 07/2022
1	Precision Medicine 07/2022
1	Salvage Therapy 01/2022
1	Traditional Medicine (Folk Remedies) 04/2014
1	Biological Therapy 11/2013
1	Segmental Mastectomy (Lumpectomy) 05/2012